RedHill Biopharma Ltd.

FDA Grants Rare Pediatric Disease Designation to Opaganib for Neuroblastoma Treatment The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to opaganib, an oral sphingosine …